                         SEQUENCE LISTING

<110>  APRILBIO CO., LTD.
 
<120>  MULTISPECIFIC ANTIBODIES, COMPOSITIONS COMPRISING THE SAME, AND 
       VECTORS AND USES THEREOF

<130>  2662-0001WO01

<150>  KR 10-2020-0009565
<151>  2020-01-24

<150>  16/878,255
<151>  2020-05-19

<160>  105   

<170>  PatentIn version 3.5

<210>  1
<211>  669
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SL335 Heavy chain DNA

<400>  1
caggtgcagc ttgtccagtc cggaggcggc cctgtgaagc ctggggggtc attgagattg       60

tcctgtgcag catccggatt tatgttcagg gcttactcca tgaactgggt gcgccaggct      120

ccagggaagg ggttggaatg ggtgtccagc atcagcagct ctggaaggta catccactac      180

gccgactccg tgaagggcag gttcaccatt tcccgggaca acgctaagaa cagcctgtac      240

ctccagatga actccctccg ggctgaggac accgccgtgt actactgcgc ccgggagaca      300

gtgatggccg ggaaagccct ggattactgg ggccaaggca ctctggtcac agtcagctca      360

gcctctacaa aaggccctag tgtgtttcct ctggccccat caagtaagag cacctcagag      420

gggaccgccg ccctgggctg cctggtcaaa gattactttc cagagcccgt gacagtgagt      480

tggaacagtg gggctctgac aagcggggtc catacatttc ccgccgtgct gcagagcagc      540

gggctgtata gcctgagcag cgtcgtcact gtgcccagct cttctctcgg cacacagact      600

tacatttgca atgtgaacca caagcccagc aacactaagg tcgataagaa ggtggagccc      660

aagtcctcc                                                              669


<210>  2
<211>  645
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SL335 Light chain DNA

<400>  2
gacatcgtcc tgacccagag ccccgggaca ctgagcctgt cccccgggga gacagccaca       60

ctgagctgca gggccagcca gtccgtcggc tccaacctgg cctggtacca gcagaagccc      120

gggcaggccc ccaggctgct gatttacggc gccagcacag gcgccacagg ggtgcccgcc      180

aggtttagcg gcagccggag cggcacagat tttacactga caatcacatc cctgcagccc      240

gaggattttg ccacatacta ctgccagcag tactactcct tcctggccaa gacattcggc      300

cagggcaccc agctggagat caagcggacc gtggccgccc ccagcgtgtt tattttcccc      360

cccagcgatg agcagctgaa gtccggcacc gcctccgtcg tgtgcctgct gaacaacttc      420

tacccccggg aggccaaggt ccagtggaag gtcgataacg ccctgcagag cgggaactcc      480

caggagtccg tgaccgagca ggactccaag gacagcacct actccctgtc caacaccctg      540

accctgagca aggccgacta cgagaagcac aaggtctacg cctgcgaggt gacccaccag      600

ggcctgtcct cccccgtgac caagagcttt aaccgggggg agtcc                      645


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker 1

<400>  3

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


<210>  4
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker 2

<400>  4

Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr 
1               5                   10                  15      


Lys Gly 
        


<210>  5
<211>  794
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  hu5c8 scFv DNA

<400>  5
atggagtggt cctgggtctt cctcttcttc ctcagcgtga ccaccggagt gctttccgac       60

atcgtcttga ctcaatctcc cgccaccctg tccgtatccc ccggagagcg tgctacaata      120

agttgccgcg caagtcagag agtgtcaagc agtacatact cctacatgca ctggtaccag      180

cagaagccag gccagcctcc aaagttgctt attaaatacg ccagcaatct tgaatccggg      240

gtacccgccc gcttctcagg atctggttct ggcacagatt ttacactcac aattagctct      300

gtcgagcctg aggacttcgc cacctattac tgccagcact cctgggagat cccccctaca      360

ttcggtcagg ggactaaact tgagataaag cggggaggcg gaggaagtgg gggtggagga      420

agcggcggag gggggagcca ggtccagctg gtgcagagtg gcgcagaagt agtaaagccc      480

ggcgcatccg ttaagctgtc ctgtaaagca agcggatata tttttacctc ctattacatg      540

tattgggtga aacaagcacc aggccaagga cttgaatgga tcggcgaaat aaatcccagc      600

aacggcgata caaattttaa tgagaagttt aagtctaaag ccacattgac tgttgataaa      660

tccgccagca ctgcatatat ggaactctct agcttgagga gtgaagatac cgcagtgtac      720

tactgcactc gtagtgatgg caggaatgac atggactctt ggggccaggg tacattggtt      780

acagtctcct cttg                                                        794


<210>  6
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha Fv, VH DNA

<400>  6
gaagtccaac ttgttgagtc cggaggaggg ctcgttcaac caggcgggtc cctgcggctt       60

tcctgtgctg cttcaggcta cgtttttaca gattacggca tgaactgggt tcggcaggcc      120

cccggtaaag gtctggaatg gatggggtgg atcaatacat acataggtga acccatatat      180

gcagattcag taaagggtcg cttcacattt tctctcgaca ctagtaagtc aacagcctac      240

ctccagatga actcccttcg tgcagaggat acagctgtgt attactgcgc ccggggttac      300

agaagctacg caatggatta ttgggggcag ggtacccttg ttaccgtctc aagt            354


<210>  7
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha Fv, VL DNA

<400>  7
gatatacaga tgacacaaag cccaagcagt ctcagtgctt ccgttggtga ccgggtcacc       60

atcacttgta aagcatccca gaacgtcgga acaaacgtag catggtacca acagaagcca      120

ggaaaggcac caaaggccct tatctactcc gcttcctttc tctactcagg cgtaccatac      180

aggttcagcg gctccggcag tggaaccgat ttcaccctta ctatttcctc actgcagcca      240

gaggacttcg ccacttacta ctgtcaacag tataatattt accccctgac atttggacag      300

ggaacaaaag ttgagattaa gcgg                                             324


<210>  8
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha dsFv, VH DNA

<400>  8
gaagtccaac ttgttgagtc cggaggaggg ctcgttcaac caggcgggtc cctgcggctt       60

tcctgtgctg cttcaggcta cgtttttaca gattacggca tgaactgggt tcggcaggcc      120

cccggtaaat gtctggaatg gatggggtgg atcaatacat acataggtga acccatatat      180

gcagattcag taaagggtcg cttcacattt tctctcgaca ctagtaagtc aacagcctac      240

ctccagatga actcccttcg tgcagaggat acagctgtgt attactgcgc ccggggttac      300

agaagctacg caatggatta ttgggggcag ggtacccttg ttaccgtctc aagt            354


<210>  9
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha dsFv, VL DNA

<400>  9
gatatacaga tgacacaaag cccaagcagt ctcagtgctt ccgttggtga ccgggtcacc       60

atcacttgta aagcatccca gaacgtcgga acaaacgtag catggtacca acagaagcca      120

ggaaaggcac caaaggccct tatctactcc gcttcctttc tctactcagg cgtaccatac      180

aggttcagcg gctccggcag tggaaccgat ttcaccctta ctatttcctc actgcagcca      240

gaggacttcg ccacttacta ctgtcaacag tataatattt accccctgac atttggatgt      300

ggaacaaaag ttgagattaa gcgg                                             324


<210>  10
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 Fv, VH DNA

<400>  10
gaggtacagc ttgtccaaag tggcgccgag gtcaaaaaac ccggagaaag tctgaaaatt       60

agttgcaaag gctccggcta ctccttcaca acttattggc ttgggtgggt acggcagatg      120

cccggaaaag gcctcgattg gatagggata atgagtcccg tagacagtga catccgctac      180

agcccttctt ttcaaggtca agttacaatg agtgttgaca aatccatcac tacagcatac      240

cttcagtgga acagcctgaa ggcaagcgat actgcaatgt attactgtgc ccgtcgccgc      300

cccgggcagg gctatttcga cttctggggc caggggacac tggtcaccgt ttcatct         357


<210>  11
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 Fv, VL DNA

<400>  11
gacatccaaa tgacacagag tccatctagc ctgagcgcct cagttggcga ccgggtaaca       60

ataacctgcc gggccagtca ggggataagc tcatggctgg catggtatca gcaaaaaccc      120

gaaaaagcac ctaaatcact tatctatgcc gctagcagct tgcaatctgg tgtaccctca      180

cgtttttctg ggagtggtag cggcacagat ttcacactca caatttcctc ccttcagccc      240

gaagatttcg ctacctacta ttgccaacag tataacattt atccttatac attcgggcaa      300

ggaacaaaat tggagataaa gcgg                                             324


<210>  12
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 dsFv, VH DNA

<400>  12
gaggtacagc ttgtccaaag tggcgccgag gtcaaaaaac ccggagaaag tctgaaaatt       60

agttgcaaag gctccggcta ctccttcaca acttattggc ttgggtgggt acggcagatg      120

cccggaaaat gtctcgattg gatagggata atgagtcccg tagacagtga catccgctac      180

agcccttctt ttcaaggtca agttacaatg agtgttgaca aatccatcac tacagcatac      240

cttcagtgga acagcctgaa ggcaagcgat actgcaatgt attactgtgc ccgtcgccgc      300

cccgggcagg gctatttcga cttctggggc caggggacac tggtcaccgt ttcatct         357


<210>  13
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 dsFv, VL DNA

<400>  13
gacatccaaa tgacacagag tccatctagc ctgagcgcct cagttggcga ccgggtaaca       60

ataacctgcc gggccagtca ggggataagc tcatggctgg catggtatca gcaaaaaccc      120

gaaaaagcac ctaaatcact tatctatgcc gctagcagct tgcaatctgg tgtaccctca      180

cgtttttctg ggagtggtag cggcacagat ttcacactca caatttcctc ccttcagccc      240

gaagatttcg ctacctacta ttgccaacag tataacattt atccttatac attcgggtgt      300

ggaacaaaat tggagataaa gcgg                                             324


<210>  14
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 Fv, VH DNA

<400>  14
gaagttcagc tggtacaatc aggagccgaa gtaaagaagc caggcgaatc ccttaaaatc       60

tcttgcaagg gaagcggcta catatttact aattactgga tcgcatgggt tcgacagatg      120

ccaggcaaag gtctggagtc catggggata atataccctg gagacagtga catacgctat      180

tccccaagtt tccaaggaca agtgaccatt tctgctgata aaagcatcac aacagcctac      240

cttcaatggt catctcttaa ggcctctgac accgcaatgt actactgtgc tcgccacgat      300

attgaggggt tcgattactg ggggcggggc acccttgtta cagttagcag t               351


<210>  15
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 Fv, VL DNA

<400>  15
gagattgtac ttacccagtc tcctggcact ctgagtttga gtcccggcga gcgcgctacc       60

ctgagttgcc gagcttcaca gtccgtcagc tcttcattct tcgcttggta ccagcaaaaa      120

cctgggcagg ccccaagatt gcttatatat ggagcctcct cccgagcaac aggcatcccc      180

gaccgactca gcggttctgg atctggcacc gatttcactt tgacaattac ccggcttgag      240

cccgaggact ttgccgtata ttattgtcaa caatacgata gcagcgcaat tactttcggg      300

caagggactc gacttgagat taaacgt                                          327


<210>  16
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer APB-A1 H DNA

<400>  16
gatcaactct agagccacca tggagtggtc ctgggtc                                37


<210>  17
<211>  56
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer APB-A1 H DNA

<400>  17
aggaagacgc ttttagaggc ggccgctcag gaggacttgg gctccacctt cttatc           56


<210>  18
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer APB-A1 L DNA

<400>  18
gatcaactct agagccacca tggagaccca cagccag                                37


<210>  19
<211>  59
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer APB-A1 L DNA

<400>  19
aggaagacgc ttttagaggc ggccgctcag gactcccccc ggttaaagct cttggtcac        59


<210>  20
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 1

<400>  20
gatcaactct agagccacca tggagtggtc ctgggt                                 36


<210>  21
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 2

<400>  21
ggaggacttg ggctccacct tcttatcgac                                        30


<210>  22
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 3

<400>  22
gtcgataaga aggtggagcc caagtcctcc                                        30


<210>  23
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 4

<400>  23
atcggcggcc gcgaagacgc ttttagatca                                        30


<210>  24
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 5

<400>  24
gatcaactct agagccacca tggagaccca cagccag                                37


<210>  25
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 6

<400>  25
ggactccccc cggttaaagc tcttggtcac                                        30


<210>  26
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 7

<400>  26
gtgaccaaga gctttaaccg gggggagtcc                                        30


<210>  27
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 8

<400>  27
atcggcggcc gcgaagacgc ttttagatca                                        30


<210>  28
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 9

<400>  28
tttaccgggg gcctgccgaa cccagttcat                                        30


<210>  29
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 10

<400>  29
gcccccggta aatgtctgga atggatgggg                                        30


<210>  30
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 11

<400>  30
atcggcggcc gcgaagacgc ttttagatca                                        30


<210>  31
<211>  70
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 12

<400>  31
ttcatgcggc cgcgaagacg cttttagatc accgcttaat ctcaactttt gttccacatc       60

caaatgtcag                                                              70


<210>  32
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 13

<400>  32
ttttccgggc atctgccgta cccacccaag                                        30


<210>  33
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 14

<400>  33
atgcccggaa aatgtctcga ttggataggg ataatg                                 36


<210>  34
<211>  70
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 15

<400>  34
ttcatgcggc cgcgaagacg cttttagatc accgctttat ctccaatttt gttccacacc       60

cgaatgtata                                                              70


<210>  35
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 16

<400>  35
tttgcctggc atctgtcgaa cccatgcgat                                        30


<210>  36
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 17

<400>  36
atgccaggca aatgtctgga gtccatgggg                                        30


<210>  37
<211>  70
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer 18

<400>  37
tacatgcggc cgcgaagacg cttttagatc aacgtttaat ctcaagtcga gtcccacacc       60

cgaaagtaat                                                              70


<210>  38
<211>  465
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  rhCD40L-his DNA

<400>  38
ggggatcaaa atcctcaaat cgctgctcac gtaattagtg aggcatcaag taagactacc       60

agcgtacttc aatgggccga gaagggctat tacactatgt caaacaacct cgtgaccctt      120

gagaacggca agcagctcac tgtaaagcgc cagggacttt attacattta tgcacaggtc      180

acattctgct caaaccggga ggcaagttca caggctccat ttatcgctag tttgtgtttg      240

aagagcccag ggagatttga gaggatactt ctccgagccg caaacaccca ttccagtgcc      300

aagccatgcg ggcagcagag catacatttg ggtggcgtgt ttgagctgca gcctggggca      360

tctgtattcg taaatgttac cgatccttct caagtttcac atggaacagg cttcacatct      420

ttcggccttc tgaaactggg ccaccaccat catcaccacc accat                      465


<210>  39
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 dsFv, VH DNA

<400>  39
gaagttcagc tggtacaatc aggagccgaa gtaaagaagc caggcgaatc ccttaaaatc       60

tcttgcaagg gaagcggcta catatttact aattactgga tcgcatgggt tcgacagatg      120

ccaggcaaat gtctggagtc catggggata atataccctg gagacagtga catacgctat      180

tccccaagtt tccaaggaca agtgaccatt tctgctgata aaagcatcac aacagcctac      240

cttcaatggt catctcttaa ggcctctgac accgcaatgt actactgtgc tcgccacgat      300

attgaggggt tcgattactg ggggcggggc acccttgtta cagttagcag t               351


<210>  40
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 dsFv, VL DNA

<400>  40
gagattgtac ttacccagtc tcctggcact ctgagtttga gtcccggcga gcgcgctacc       60

ctgagttgcc gagcttcaca gtccgtcagc tcttcattct tcgcttggta ccagcaaaaa      120

cctgggcagg ccccaagatt gcttatatat ggagcctcct cccgagcaac aggcatcccc      180

gaccgactca gcggttctgg atctggcacc gatttcactt tgacaattac ccggcttgag      240

cccgaggact ttgccgtata ttattgtcaa caatacgata gcagcgcaat tactttcggg      300

tgtgggactc gacttgagat taaacgt                                          327


<210>  41
<211>  483
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APB-A1 Heavy chain

<400>  41

Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Arg Ala Ser Gln Arg Val Ser Ser Ser 
            20                  25                  30          


Thr Tyr Ser Tyr Met His Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Lys Tyr Ala Ser Asn Leu Glu Ser Gly Val Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Val Glu Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Ser Trp 
                85                  90                  95      


Glu Ile Pro Pro Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 110         


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln 
        115                 120                 125             


Val Gln Leu Val Gln Ser Gly Ala Glu Val Val Lys Pro Gly Ala Ser 
    130                 135                 140                 


Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Ser Tyr Tyr 
145                 150                 155                 160 


Met Tyr Trp Val Lys Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly 
                165                 170                 175     


Glu Ile Asn Pro Ser Asn Gly Asp Thr Asn Phe Asn Glu Lys Phe Lys 
            180                 185                 190         


Ser Lys Ala Thr Leu Thr Val Asp Lys Ser Ala Ser Thr Ala Tyr Met 
        195                 200                 205             


Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Thr 
    210                 215                 220                 


Arg Ser Asp Gly Arg Asn Asp Met Asp Ser Trp Gly Gln Gly Thr Leu 
225                 230                 235                 240 


Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
                245                 250                 255     


Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Pro Val 
            260                 265                 270         


Lys Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Met 
        275                 280                 285             


Phe Arg Ala Tyr Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly 
    290                 295                 300                 


Leu Glu Trp Val Ser Ser Ile Ser Ser Ser Gly Arg Tyr Ile His Tyr 
305                 310                 315                 320 


Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys 
                325                 330                 335     


Asn Ser Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala 
            340                 345                 350         


Val Tyr Tyr Cys Ala Arg Glu Thr Val Met Ala Gly Lys Ala Leu Asp 
        355                 360                 365             


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys 
    370                 375                 380                 


Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Glu 
385                 390                 395                 400 


Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro 
                405                 410                 415     


Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr 
            420                 425                 430         


Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val 
        435                 440                 445             


Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn 
    450                 455                 460                 


Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro 
465                 470                 475                 480 


Lys Ser Ser 
            


<210>  42
<211>  478
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APB-A1 Light chain

<400>  42

Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Arg Ala Ser Gln Arg Val Ser Ser Ser 
            20                  25                  30          


Thr Tyr Ser Tyr Met His Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Lys Tyr Ala Ser Asn Leu Glu Ser Gly Val Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Val Glu Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Ser Trp 
                85                  90                  95      


Glu Ile Pro Pro Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 110         


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln 
        115                 120                 125             


Val Gln Leu Val Gln Ser Gly Ala Glu Val Val Lys Pro Gly Ala Ser 
    130                 135                 140                 


Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Ser Tyr Tyr 
145                 150                 155                 160 


Met Tyr Trp Val Lys Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly 
                165                 170                 175     


Glu Ile Asn Pro Ser Asn Gly Asp Thr Asn Phe Asn Glu Lys Phe Lys 
            180                 185                 190         


Ser Lys Ala Thr Leu Thr Val Asp Lys Ser Ala Ser Thr Ala Tyr Met 
        195                 200                 205             


Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Thr 
    210                 215                 220                 


Arg Ser Asp Gly Arg Asn Asp Met Asp Ser Trp Gly Gln Gly Thr Leu 
225                 230                 235                 240 


Val Thr Val Ser Ser Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser 
                245                 250                 255     


Gly Glu Gly Ser Thr Lys Gly Asp Ile Val Leu Thr Gln Ser Pro Gly 
            260                 265                 270         


Thr Leu Ser Leu Ser Pro Gly Glu Thr Ala Thr Leu Ser Cys Arg Ala 
        275                 280                 285             


Ser Gln Ser Val Gly Ser Asn Leu Ala Trp Tyr Gln Gln Lys Pro Gly 
    290                 295                 300                 


Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Thr Gly Ala Thr Gly 
305                 310                 315                 320 


Val Pro Ala Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu 
                325                 330                 335     


Thr Ile Thr Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln 
            340                 345                 350         


Gln Tyr Tyr Ser Phe Leu Ala Lys Thr Phe Gly Gln Gly Thr Gln Leu 
        355                 360                 365             


Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro 
    370                 375                 380                 


Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu 
385                 390                 395                 400 


Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn 
                405                 410                 415     


Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser 
            420                 425                 430         


Lys Asp Ser Thr Tyr Ser Leu Ser Asn Thr Leu Thr Leu Ser Lys Ala 
        435                 440                 445             


Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly 
    450                 455                 460                 


Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Ser 
465                 470                 475             


<210>  43
<211>  735
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  hu5c8 scFv DNA linked to N term of variable heavy chain of SL335

<400>  43
gatatcgtgc tgacccagtc tcctgccaca ctgagtgtgt ctccaggcga gagagccacc       60

atctcttgca gagcttccca gagagtgtcc tcctccacct actcctacat gcactggtat      120

cagcagaagc ccggccagcc tcctaagctg ctgattaagt acgcctccaa cctggaatcc      180

ggcgtgccag ccagattttc tggctctgga tctggcaccg acttcaccct gaccatcagc      240

tctgtggaac ctgaggactt cgccacctac tactgccagc actcttggga gatcccacct      300

acctttggcg gaggcaccaa gctggaaatc aaaagaggtg gcggaggatc tggcggtggt      360

ggttcaggcg gaggcggatc tcaggttcag ttggttcagt ctggcgccga ggttgtgaaa      420

cctggcgctt ctgtgaagct gtcctgcaag gcctccggct acatcttcac cagctactac      480

atgtactggg tcaagcaggc ccctggacag ggacttgagt ggatcggcga gatcaaccct      540

tccaacggcg acaccaactt caacgagaag ttcaagtcca aggctaccct gaccgtggac      600

aagtctgcct ccaccgctta catggaactg tctagcctga gaagcgagga caccgccgtg      660

tactactgca ccagatccga cggcagaaac gacatggatt cttggggcca gggcaccctg      720

gttacagttt cttct                                                       735


<210>  44
<211>  735
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  hu5c8 scFv DNA linked to N term of variable light chain of SL335

<400>  44
gatatcgtgc tgacccagtc tcctgccaca ctgagtgtgt ctccaggcga gagagccacc       60

atctcttgca gagcttccca gagagtgtcc tcctccacct actcctacat gcactggtat      120

cagcagaagc ccggccagcc tcctaagctg ctgattaagt acgcctccaa cctggaatcc      180

ggcgtgccag ccagattttc tggctctgga tctggcaccg acttcaccct gaccatcagc      240

tctgtggaac ctgaggactt cgccacctac tactgccagc actcttggga gatcccacct      300

acctttggcg gaggcaccaa gctggaaatc aaaagaggtg gcggaggatc tggcggtggt      360

ggttcaggcg gaggcggatc tcaggttcag ttggttcagt ctggcgccga ggttgtgaaa      420

cctggcgctt ctgtgaagct gtcctgcaag gcctccggct acatcttcac cagctactac      480

atgtactggg tcaagcaggc ccctggacag ggacttgagt ggatcggcga gatcaaccct      540

tccaacggcg acaccaactt caacgagaag ttcaagtcca aggctaccct gaccgtggac      600

aagtctgcct ccaccgctta catggaactg tctagcctga gaagcgagga caccgccgtg      660

tactactgca ccagatccga cggcagaaac gacatggatt cttggggcca gggcaccctg      720

gttacagtgt ccagt                                                       735


<210>  45
<211>  223
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SL335 Heavy chain

<400>  45

Gln Val Gln Leu Val Gln Ser Gly Gly Gly Pro Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Met Phe Arg Ala Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Gly Arg Tyr Ile His Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Thr Val Met Ala Gly Lys Ala Leu Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val 
        115                 120                 125             


Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Glu Gly Thr Ala Ala 
    130                 135                 140                 


Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser 
145                 150                 155                 160 


Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val 
                165                 170                 175     


Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro 
            180                 185                 190         


Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys 
        195                 200                 205             


Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Ser 
    210                 215                 220             


<210>  46
<211>  215
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SL335 Light chain

<400>  46

Asp Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Thr Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Gly Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Gly Ala Thr Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Phe Leu Ala 
                85                  90                  95      


Lys Thr Phe Gly Gln Gly Thr Gln Leu Glu Ile Lys Arg Thr Val Ala 
            100                 105                 110         


Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser 
        115                 120                 125             


Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu 
    130                 135                 140                 


Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser 
145                 150                 155                 160 


Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu 
                165                 170                 175     


Ser Asn Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val 
            180                 185                 190         


Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys 
        195                 200                 205             


Ser Phe Asn Arg Gly Glu Ser 
    210                 215 


<210>  47
<211>  245
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  hu5c8 scFv

<400>  47

Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Arg Ala Ser Gln Arg Val Ser Ser Ser 
            20                  25                  30          


Thr Tyr Ser Tyr Met His Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Lys Tyr Ala Ser Asn Leu Glu Ser Gly Val Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Val Glu Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Ser Trp 
                85                  90                  95      


Glu Ile Pro Pro Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 110         


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln 
        115                 120                 125             


Val Gln Leu Val Gln Ser Gly Ala Glu Val Val Lys Pro Gly Ala Ser 
    130                 135                 140                 


Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Ser Tyr Tyr 
145                 150                 155                 160 


Met Tyr Trp Val Lys Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly 
                165                 170                 175     


Glu Ile Asn Pro Ser Asn Gly Asp Thr Asn Phe Asn Glu Lys Phe Lys 
            180                 185                 190         


Ser Lys Ala Thr Leu Thr Val Asp Lys Ser Ala Ser Thr Ala Tyr Met 
        195                 200                 205             


Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Thr 
    210                 215                 220                 


Arg Ser Asp Gly Arg Asn Asp Met Asp Ser Trp Gly Gln Gly Thr Leu 
225                 230                 235                 240 


Val Thr Val Ser Ser 
                245 


<210>  48
<211>  245
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  hu5c8 scFv linked to N term of variable heavy chain of SL335

<400>  48

Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Arg Ala Ser Gln Arg Val Ser Ser Ser 
            20                  25                  30          


Thr Tyr Ser Tyr Met His Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Lys Tyr Ala Ser Asn Leu Glu Ser Gly Val Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Val Glu Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Ser Trp 
                85                  90                  95      


Glu Ile Pro Pro Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 110         


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln 
        115                 120                 125             


Val Gln Leu Val Gln Ser Gly Ala Glu Val Val Lys Pro Gly Ala Ser 
    130                 135                 140                 


Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Ser Tyr Tyr 
145                 150                 155                 160 


Met Tyr Trp Val Lys Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly 
                165                 170                 175     


Glu Ile Asn Pro Ser Asn Gly Asp Thr Asn Phe Asn Glu Lys Phe Lys 
            180                 185                 190         


Ser Lys Ala Thr Leu Thr Val Asp Lys Ser Ala Ser Thr Ala Tyr Met 
        195                 200                 205             


Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Thr 
    210                 215                 220                 


Arg Ser Asp Gly Arg Asn Asp Met Asp Ser Trp Gly Gln Gly Thr Leu 
225                 230                 235                 240 


Val Thr Val Ser Ser 
                245 


<210>  49
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha Fv, VH

<400>  49

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Val Phe Thr Asp Tyr 
            20                  25                  30          


Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Tyr Ile Gly Glu Pro Ile Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Phe Ser Leu Asp Thr Ser Lys Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Arg Ser Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  50
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha Fv, VL

<400>  50

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Asn Val Gly Thr Asn 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Tyr Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ile Tyr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105             


<210>  51
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha dsFv, VH

<400>  51

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Val Phe Thr Asp Tyr 
            20                  25                  30          


Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Cys Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Tyr Ile Gly Glu Pro Ile Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Phe Ser Leu Asp Thr Ser Lys Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Arg Ser Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  52
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-TNF-alpha dsFv, VL

<400>  52

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Asn Val Gly Thr Asn 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Tyr Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ile Tyr Pro Leu 
                85                  90                  95      


Thr Phe Gly Cys Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105             


<210>  53
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 Fv, VH

<400>  53

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Thr Tyr 
            20                  25                  30          


Trp Leu Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Asp Trp Ile 
        35                  40                  45              


Gly Ile Met Ser Pro Val Asp Ser Asp Ile Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Met Ser Val Asp Lys Ser Ile Thr Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Asn Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Arg Pro Gly Gln Gly Tyr Phe Asp Phe Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  54
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 Fv, VL

<400>  54

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Glu Lys Ala Pro Lys Ser Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ile Tyr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105             


<210>  55
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 dsFv, VH

<400>  55

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Thr Tyr 
            20                  25                  30          


Trp Leu Gly Trp Val Arg Gln Met Pro Gly Lys Cys Leu Asp Trp Ile 
        35                  40                  45              


Gly Ile Met Ser Pro Val Asp Ser Asp Ile Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Met Ser Val Asp Lys Ser Ile Thr Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Asn Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Arg Pro Gly Gln Gly Tyr Phe Asp Phe Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  56
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IL-23 dsFv, VL

<400>  56

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Glu Lys Ala Pro Lys Ser Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ile Tyr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Cys Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105             


<210>  57
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 Fv, VH

<400>  57

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ile Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Ala Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Ser Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Ile Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Thr Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg His Asp Ile Glu Gly Phe Asp Tyr Trp Gly Arg Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  58
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 Fv, VL

<400>  58

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Phe Phe Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Leu Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Ser Ser Ala 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg 
            100                 105                 


<210>  59
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 dsFv, VH

<400>  59

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ile Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Ala Trp Val Arg Gln Met Pro Gly Lys Cys Leu Glu Ser Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Ile Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Thr Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg His Asp Ile Glu Gly Phe Asp Tyr Trp Gly Arg Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  60
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-IFNAR1 dsFv, VL

<400>  60

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Phe Phe Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Leu Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Ser Ser Ala 
                85                  90                  95      


Ile Thr Phe Gly Cys Gly Thr Arg Leu Glu Ile Lys Arg 
            100                 105                 


<210>  61
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR1

<400>  61

Ser Tyr Gly Ile Ser 
1               5   


<210>  62
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR2

<400>  62

Trp Ile Asn Thr Tyr Ser Gly Gly Thr Lys Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  63
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR3

<400>  63

Leu Gly His Cys Gln Arg Gly Ile Cys Ser Asp Ala Leu Asp Thr 
1               5                   10                  15  


<210>  64
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR2

<400>  64

Arg Ile Asn Thr Tyr Asn Gly Asn Thr Gly Tyr Ala Gln Arg Leu Gln 
1               5                   10                  15      


Gly 
    


<210>  65
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR1

<400>  65

Asn Tyr Gly Ile His 
1               5   


<210>  66
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR2

<400>  66

Ser Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  67
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR3

<400>  67

Asp Val His Tyr Tyr Gly Ser Gly Ser Tyr Tyr Asn Ala Phe Asp Ile 
1               5                   10                  15      


<210>  68
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR1

<400>  68

Ser Tyr Ala Met Ser 
1               5   


<210>  69
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR2

<400>  69

Val Ile Ser His Asp Gly Gly Phe Gln Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  70
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR3

<400>  70

Ala Gly Trp Leu Arg Gln Tyr Gly Met Asp Val 
1               5                   10      


<210>  71
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR1

<400>  71

Ala Tyr Trp Ile Ala 
1               5   


<210>  72
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR2

<400>  72

Met Ile Trp Pro Pro Asp Ala Asp Ala Arg Tyr Ser Pro Ser Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  73
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR3

<400>  73

Leu Tyr Ser Gly Ser Tyr Ser Pro 
1               5               


<210>  74
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR1

<400>  74

Ala Tyr Ser Met Asn 
1               5   


<210>  75
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR2

<400>  75

Ser Ile Ser Ser Ser Gly Arg Tyr Ile His Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  76
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VH CDR3

<400>  76

Glu Thr Val Met Ala Gly Lys Ala Leu Asp Tyr 
1               5                   10      


<210>  77
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR1

<400>  77

Arg Ala Ser Gln Ser Ile Ser Arg Tyr Leu Asn 
1               5                   10      


<210>  78
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR2

<400>  78

Gly Ala Ser Arg Leu Glu Ser 
1               5           


<210>  79
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR3

<400>  79

Gln Gln Ser Asp Ser Val Pro Val Thr 
1               5                   


<210>  80
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR1

<400>  80

Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210>  81
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR2

<400>  81

Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210>  82
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR3

<400>  82

Gln Gln Ser Tyr Ser Thr Pro Pro Tyr Thr 
1               5                   10  


<210>  83
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR1

<400>  83

Arg Ala Ser Gln Ser Ile Phe Asn Tyr Val Ala 
1               5                   10      


<210>  84
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR2

<400>  84

Asp Ala Ser Asn Arg Ala Thr 
1               5           


<210>  85
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR3

<400>  85

Gln Gln Arg Ser Lys Trp Pro Pro Thr Trp Thr 
1               5                   10      


<210>  86
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR1

<400>  86

Arg Ala Ser Glu Thr Val Ser Ser Arg Gln Leu Ala 
1               5                   10          


<210>  87
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR2

<400>  87

Gly Ala Ser Ser Arg Ala Thr 
1               5           


<210>  88
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR3

<400>  88

Gln Gln Tyr Gly Ser Ser Pro Arg Thr 
1               5                   


<210>  89
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR1

<400>  89

Arg Ala Ser Gln Ser Val Ser Ser Ser Ser Leu Ala 
1               5                   10          


<210>  90
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR3

<400>  90

Gln Lys Tyr Ser Ser Tyr Pro Leu Thr 
1               5                   


<210>  91
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR1

<400>  91

Arg Ala Ser Gln Ser Val Gly Ser Asn Leu Ala 
1               5                   10      


<210>  92
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR2

<400>  92

Gly Ala Ser Thr Gly Ala Thr 
1               5           


<210>  93
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin VL CDR3

<400>  93

Gln Gln Tyr Tyr Ser Phe Leu Ala Lys Thr 
1               5                   10  


<210>  94
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, heavy chain variable domain (VH domain)

<400>  94

Gln Val Gln Leu Leu Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Trp Ile Asn Thr Tyr Ser Gly Gly Thr Lys Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Gly Leu Lys Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly His Cys Gln Arg Gly Ile Cys Ser Asp Ala Leu Asp 
            100                 105                 110         


Thr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  95
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, heavy chain variable domain (VH domain)

<400>  95

Glu Val Gln Leu Leu Gln Ser Gly Ala Glu Val Lys Glu Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Asn Thr Tyr Asn Gly Asn Thr Gly Tyr Ala Gln Arg Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Ile Ala Tyr 
65                  70                  75                  80  


Met Glu Val Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly His Cys Gln Arg Gly Ile Cys Ser Asp Ala Leu Asp 
            100                 105                 110         


Thr Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  96
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, heavy chain variable domain (VH domain)

<400>  96

Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Thr Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Asn Tyr 
            20                  25                  30          


Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ser Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Arg Asn Thr Val His 
65                  70                  75                  80  


Val Gln Met Asp Ser Leu Arg Gly Gly Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val His Tyr Tyr Gly Ser Gly Ser Tyr Tyr Asn Ala Phe 
            100                 105                 110         


Asp Ile Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  97
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, heavy chain variable domain (VH domain)

<400>  97

Gln Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Ser Val Ile Ser His Asp Gly Gly Phe Gln Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Gly Trp Leu Arg Gln Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  98
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, heavy chain variable domain (VH domain)

<400>  98

Glu Val Gln Leu Val Gln Ser Gly Thr Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Ile Ser Gly Tyr Ser Phe Thr Ala Tyr 
            20                  25                  30          


Trp Ile Ala Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Met Ile Trp Pro Pro Asp Ala Asp Ala Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Phe Ser Val Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp His Ser Leu Lys Thr Ser Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Tyr Ser Gly Ser Tyr Ser Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  99
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, heavy chain variable domain (VH domain)

<400>  99

Gln Val Gln Leu Val Gln Ser Gly Gly Gly Pro Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Met Phe Arg Ala Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Gly Arg Tyr Ile His Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Thr Val Met Ala Gly Lys Ala Leu Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  100
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, light chain variable domain (VL domain)

<400>  100

Glu Leu Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Arg Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Ser Val Pro Val 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg 
            100                 105             


<210>  101
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, light chain variable domain (VL domain)

<400>  101

Asp Ile Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Pro 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 


<210>  102
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, light chain variable domain (VL domain)

<400>  102

Glu Leu Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Phe Asn Tyr 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Lys Trp Pro Pro 
                85                  90                  95      


Thr Trp Thr Phe Gly Gln Gly Thr Arg Val Asp Ile Lys Arg 
            100                 105                 110 


<210>  103
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, light chain variable domain (VL domain)

<400>  103

Glu Leu Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Glu Thr Val Ser Ser Arg 
            20                  25                  30          


Gln Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Ser Ala Val Phe Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Arg Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 


<210>  104
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, light chain variable domain (VL domain)

<400>  104

Glu Leu Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Ala Ala Thr Tyr Tyr Cys Gln Lys Tyr Ser Ser Tyr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg 
            100                 105                 


<210>  105
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-serum albumin, light chain variable domain (VL domain)

<400>  105

Glu Leu Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Thr Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Gly Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Gly Ala Thr Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Phe Leu Ala 
                85                  90                  95      


Lys Thr Phe Gly Gln Gly Thr Gln Leu Glu Ile Lys Arg 
            100                 105                 


